<i>In vivo</i> assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3
Jana Schmidt(University of Tübingen), Olaf Rieß(University of Tübingen), Matthias Golla(University of Tübingen), Thorsten Schmidt(University of Tübingen), Lisa Soleymani Lehmann(Brigham and Women's Hospital), Jonasz Jeremiasz Weber(University Hospitals of the Ruhr-University of Bochum), Jeannette Hübener‐Schmid(Bernstein Center for Computational Neuroscience Tübingen)
Cited by 34
Related Papers
Genome-wide association study reveals genetic risk underlying Parkinson's disease
|Nature Genetics|2009|2k
14-3-3 proteins in the nervous system
|Nature reviews. Neuroscience|2003|625
Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease
|Human Molecular Genetics|2005|566
The TRIPOD-LLM reporting guideline for studies using large language models
|Nature Medicine|2025|340
<i>SNCA</i> variants are associated with increased risk for multiple system atrophy
|Annals of Neurology|2009|283